{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:50:52Z","timestamp":1793645452717,"version":"4.5.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T00:00:00Z","timestamp":1373328000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1038\/nrgastro.2013.117","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T05:27:46Z","timestamp":1373347666000},"page":"585-595","source":"Crossref","is-referenced-by-count":312,"title":["Extraintestinal manifestations and complications in IBD"],"prefix":"10.1038","volume":"10","author":[{"given":"Claudia","family":"Ott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Sch\u00f6lmerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,9]]},"reference":[{"key":"BFnrgastro2013117_CR1","doi-asserted-by":"publisher","first-page":"4819","DOI":"10.3748\/wjg.v12.i30.4819","volume":"12","author":"KS Rothfuss","year":"2006","unstructured":"Rothfuss, K. S., Stange, E. F. & Herrlinger, K. R. Extraintestinal manifestations and complications in inflammatory bowel diseases. World. J. Gastroenterol. 12, 4819\u20134831 (2006).","journal-title":"World. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR2","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.3748\/wjg.v11.i46.7227","volume":"11","author":"S Danese","year":"2005","unstructured":"Danese, S.  et al. Extraintestinal manifestations in inflammatory bowel disease. World. J. Gastroenterol. 11, 7227\u20137236 (2005).","journal-title":"World. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR3","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/0016-5085(79)90391-3","volume":"77","author":"GB Rankin","year":"1979","unstructured":"Rankin, G. B., Watts, H. D., Melnyk, C. S. & Kelley, M. L. Jr. National Cooperative Crohn's Disease Study: extraintestinal manifestations and perianal complications. Gastroenterology 77, 914\u2013920 (1979).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013117_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0889-8553(01)00019-X","volume":"31","author":"CG Su","year":"2002","unstructured":"Su, C. G., Judge, T. A. & Lichtenstein, G. R. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol. Clin. North Am. 31, 307\u2013327 (2002).","journal-title":"Gastroenterol. Clin. North Am."},{"key":"BFnrgastro2013117_CR5","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","volume":"96","author":"CN Bernstein","year":"2001","unstructured":"Bernstein, C. N., Blanchard, J. F., Rawsthorne, P. & Yu, N. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am. J. Gastroenterol. 96, 1116\u20131122 (2001).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR6","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","volume":"9","author":"L Lakatos","year":"2003","unstructured":"Lakatos, L.  et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J. Gastroenterol. 9, 2300\u20132307 (2003).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2013117_CR7","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/00054725-200405000-00005","volume":"10","author":"E Ricart","year":"2004","unstructured":"Ricart, E.  et al. Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case\u2013control study. Inflamm. Bowel Dis. 10, 207\u2013214 (2004).","journal-title":"Inflamm. Bowel Dis."},{"issue":"Suppl. 2","key":"BFnrgastro2013117_CR8","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.1016\/S1590-8658(08)60534-4","volume":"40","author":"S Ardizzone","year":"2008","unstructured":"Ardizzone, S., Puttini, P. S., Cassinotti, A. & Porro, G. B. Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis. 40 (Suppl. 2), S253\u2013S259 (2008).","journal-title":"Dig Liver Dis."},{"key":"BFnrgastro2013117_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1026629528233","volume":"44","author":"KM Das","year":"1999","unstructured":"Das, K. M. Relationship of extraintestinal involvements in inflammatory bowel disease: new insights into autoimmune pathogenesis. Dig. Dis. Sci. 44, 1\u201313 (1999).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2013117_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","volume":"359","author":"AJ Grant","year":"2002","unstructured":"Grant, A. J., Lalor, P. F., Salmi, M., Jalkanen, S. & Adams, D. H. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. Lancet 359, 150\u2013157 (2002).","journal-title":"Lancet"},{"key":"BFnrgastro2013117_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/00054725-199805000-00026","volume":"4","author":"M Salmi","year":"1998","unstructured":"Salmi, M. & Jalkanen, S. Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD. Inflamm. Bowel Dis. 4, 149\u2013156 (1998).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2013117_CR12","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.4049\/jimmunol.166.7.4650","volume":"166","author":"M Salmi","year":"2001","unstructured":"Salmi, M. & Jalkanen S. Human leukocyte subpopulations from inflamed gut bind to joint vasculature using distinct sets of adhesion molecules. J. Immunol. 166, 4650\u20134657 (2001).","journal-title":"J. Immunol."},{"key":"BFnrgastro2013117_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1136\/gut.38.5.738","volume":"38","author":"J Satsangi","year":"1996","unstructured":"Satsangi, J., Grootscholten, C., Holt, H. & Jewell, D. P. Clinical patterns of familial inflammatory bowel disease. Gut 38, 738\u2013741 (1996).","journal-title":"Gut"},{"key":"BFnrgastro2013117_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0016-5085(00)70209-5","volume":"118","author":"TR Orchard","year":"2000","unstructured":"Orchard, T. R.  et al. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 118, 274\u2013278 (2000).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013117_CR15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1053\/gast.2002.35396","volume":"123","author":"TR Orchard","year":"2002","unstructured":"Orchard, T. R.  et al. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 123, 714\u2013718 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013117_CR16","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1136\/gut.17.11.906","volume":"17","author":"EG Mallas","year":"1976","unstructured":"Mallas E G., Mackintosh, P., Asquith, P. & Cooke, W. T. Histocompatibility antigens in inflammatory bowel disease. Their clinical significance and their association with arthropathy with special reference to HLA-B27 (W27). Gut 17, 906\u2013910 (1976).","journal-title":"Gut"},{"key":"BFnrgastro2013117_CR17","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1053\/gast.1997.v112.pm9178675","volume":"112","author":"M Roussomoustakaki","year":"1997","unstructured":"Roussomoustakaki, M.  et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 112, 1845\u20131853 (1997).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013117_CR18","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/ard.2004.021774","volume":"63","author":"H Peeters","year":"2004","unstructured":"Peeters, H.  et al. Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn's disease. Ann. Rheum. Dis. 63, 1131\u20131134 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2013117_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","volume":"23","author":"FT Veloso","year":"1996","unstructured":"Veloso, F. T., Carvalho, J. & Magro, F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J. Clin. Gastroenterol. 23, 29\u201334 (1996).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2013117_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.crohns.2009.11.005","volume":"4","author":"LK Brakenhoff","year":"2010","unstructured":"Brakenhoff, L. K., van der Heijde, D. M., Hommes, D. W., Huizinga, T. W. & Fidder, H. H. The joint\u2013gut axis in inflammatory bowel diseases. J. Crohns Colitis 4, 257\u2013268 (2010).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2013117_CR21","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1080\/003655201317097173","volume":"36","author":"C Salvarani","year":"2001","unstructured":"Salvarani, C.  et al. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand. J. Gastroenterol. 36, 1307\u20131313 (2001).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR22","first-page":"2860","volume":"27","author":"K de Vlam","year":"2000","unstructured":"de Vlam, K.  et al. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J. Rheumatol. 27, 2860\u20132865 (2000).","journal-title":"J. Rheumatol."},{"key":"BFnrgastro2013117_CR23","first-page":"1755","volume":"32","author":"O Palm","year":"2005","unstructured":"Palm, O., Bernklev, T., Moum, B. & Gran, J. T. Non-inflammatory joint pain in patients with inflammatory bowel disease is prevalent and has a significant impact on health related quality of life. J. Rheumatol. 32, 1755\u20131759 (2005).","journal-title":"J. Rheumatol."},{"key":"BFnrgastro2013117_CR24","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1093\/rheumatology\/40.11.1256","volume":"40","author":"O Palm","year":"2001","unstructured":"Palm, O., Moum, B., Jahnsen, J. & Gran, J. T. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford) 40, 1256\u20131261 (2001).","journal-title":"Rheumatology (Oxford)"},{"key":"BFnrgastro2013117_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/gut.42.3.387","volume":"42","author":"TR Orchard","year":"1998","unstructured":"Orchard, T. R., Wordsworth, B. P. & Jewell, D. P. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 42, 387\u2013391 (1998).","journal-title":"Gut"},{"key":"BFnrgastro2013117_CR26","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/ibd.20942","volume":"15","author":"LA Bourikas","year":"2009","unstructured":"Bourikas, L. A. & Papadakis, K. A. Musculoskeletal manifestations of inflammatory bowel disease. Inflamm. Bowel Dis. 15, 1915\u20131924 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2013117_CR27","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.2165\/11638120-000000000-00000","volume":"72","author":"G Trikudanathan","year":"2012","unstructured":"Trikudanathan, G., Venkatesh, P. G. & Navaneethan, U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs 72, 2333\u20132349 (2012).","journal-title":"Drugs"},{"key":"BFnrgastro2013117_CR28","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrrheum.2012.42","volume":"8","author":"L Van Praet","year":"2012","unstructured":"Van Praet, L., Jacques, P., Van den Bosch, F. & Elewaut, D. The transition of acute to chronic bowel inflammation in spondyloarthritis. Nat. Rev. Rheumatol. 8, 288\u2013295 (2012).","journal-title":"Nat. Rev. Rheumatol."},{"key":"BFnrgastro2013117_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/bfgp\/elr023","volume":"10","author":"MA Brown","year":"2011","unstructured":"Brown, M. A. Progress in the genetics of ankylosing spondylitis. Brief Funct. Genomics 10, 249\u2013257 (2011).","journal-title":"Brief Funct. Genomics"},{"key":"BFnrgastro2013117_CR30","first-page":"2273","volume":"22","author":"H Mielants","year":"1995","unstructured":"Mielants, H.  et al. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J. Rheumatol. 22, 2273\u20132278 (1995).","journal-title":"J. Rheumatol."},{"key":"BFnrgastro2013117_CR31","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1136\/ard.55.4.268","volume":"55","author":"MA Brown","year":"1996","unstructured":"Brown, M. A.  et al. HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann. Rheum. Dis. 55, 268\u2013270 (1996).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2013117_CR32","first-page":"511","volume":"29","author":"O Palm","year":"2002","unstructured":"Palm, O., Moum, B., Ongre, A. & Gran, J. T. Prevalence of ankylosing spondylitis and other spondyloarthropathies among patients with inflammatory bowel disease: a population study (the IBSEN study). J. Rheumatol. 29, 511\u2013515 (2002).","journal-title":"J. Rheumatol."},{"key":"BFnrgastro2013117_CR33","first-page":"518","volume":"30","author":"S Steer","year":"2003","unstructured":"Steer, S.  et al. Low back pain, sacroiliitis, and the relationship with HLA-B27 in Crohn's disease. J. Rheumatol. 30, 518\u2013522 (2003).","journal-title":"J. Rheumatol."},{"key":"BFnrgastro2013117_CR34","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.22812","volume":"56","author":"B Thjodleifsson","year":"2007","unstructured":"Thjodleifsson, B., Geirsson, A. J., Bjornsson, S. & Bjarnason, I. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum. 56, 2633\u20132639 (2007).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2013117_CR35","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1002\/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C","volume":"42","author":"DO Clegg","year":"1999","unstructured":"Clegg, D. O., Reda, D. J. & Abdellatif, M. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study. Arthritis Rheum. 42, 2325\u20132329 (1999).","journal-title":"Arthritis Rheum."},{"key":"BFnrgastro2013117_CR36","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s00228-009-0719-3","volume":"65","author":"H Kefalakes","year":"2009","unstructured":"Kefalakes, H., Stylianides, T. J., Amanakis, G. & Kolios, G. Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality? Eur. J. Clin. Pharmacol. 65, 963\u2013970 (2009).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"BFnrgastro2013117_CR37","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cgh.2005.12.002","volume":"4","author":"WJ Sandborn","year":"2006","unstructured":"Sandborn, W. J.  et al. Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study. Clin. Gastroenterol. Hepatol. 4, 203\u2013211 (2006).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013117_CR38","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1046\/j.1365-2036.2003.01596.x","volume":"17","author":"W Reinisch","year":"2003","unstructured":"Reinisch, W.  et al. An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia. Aliment. Pharmacol. Ther. 17, 1371\u20131380 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2013117_CR39","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1572-0241.2002.05608.x","volume":"97","author":"U Mahadevan","year":"2002","unstructured":"Mahadevan, U., Loftus, E. V. Jr, Tremaine, W. J. & Sandborn, W. J. Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease. Am. J. Gastroenterol. 97, 910\u2013914 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1572-0241.2006.00384.x","volume":"101","author":"Y El Miedany","year":"2006","unstructured":"El Miedany, Y., Youssef, S., Ahmed, I. & El Gaafary, M. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Am. J. Gastroenterol. 101, 311\u2013317 (2006).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR41","first-page":"24","volume":"78","author":"DO Clegg","year":"2006","unstructured":"Clegg, D. O. Treatment of ankylosing spondylitis. J. Rheumatol. Suppl. 78, 24\u201331 (2006).","journal-title":"J. Rheumatol. Suppl."},{"key":"BFnrgastro2013117_CR42","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/S0140-6736(00)03239-6","volume":"356","author":"F Van den Bosch","year":"2000","unstructured":"Van den Bosch, F., Kruithof, E., De Vos, M., De Keyser, F. & Mielants, H. Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet 356, 1821\u20131822 (2000).","journal-title":"Lancet"},{"key":"BFnrgastro2013117_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00124743-200104000-00002","volume":"7","author":"MH Ellman","year":"2001","unstructured":"Ellman, M. H., Hanauer, S., Sitrin, M. & Cohen R. Crohn's disease arthritis treated with infliximab: an open trial in four patients. J. Clin. Rheumatol. 7, 67\u201371 (2001).","journal-title":"J. Clin. Rheumatol."},{"key":"BFnrgastro2013117_CR44","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1111\/j.1572-0241.2002.06064.x","volume":"97","author":"H Herfarth","year":"2002","unstructured":"Herfarth, H.  et al. Improvement of arthritis and arthralgia after treatment with infliximab (Remicade) in a German prospective, open-label, multicenter trial in refractory Crohn's disease. Am. J. Gastroenterol. 97, 2688\u20132690 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR45","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1136\/ard.2003.012450","volume":"63","author":"S Generini","year":"2004","unstructured":"Generini, S.  et al. Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations. Ann. Rheum. Dis. 63, 1664\u20131669 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrgastro2013117_CR46","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1136\/ard.2005.041129","volume":"65","author":"J Zochling","year":"2006","unstructured":"Zochling J., van der Heijde, D., Dougados, M. & Braun, J. Current evidence for the management of ankylosing spondylitis: a systematic literature review for the ASAS\/EULAR management recommendations in ankylosing spondylitis. Ann. Rheum. Dis. 65, 423\u2013432 (2006).","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl. 1","key":"BFnrgastro2013117_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000341950","volume":"86","author":"PL Lakatos","year":"2012","unstructured":"Lakatos, P. L.  et al. Treatment of extraintestinal manifestations in inflammatory bowel disease. Digestion 86 (Suppl. 1), 28\u201335 (2012).","journal-title":"Digestion"},{"key":"BFnrgastro2013117_CR48","doi-asserted-by":"publisher","first-page":"211.e1","DOI":"10.1016\/j.jaad.2012.10.036","volume":"68","author":"B Thrash","year":"2013","unstructured":"Thrash, B., Patel, M., Shah, K. R., Boland, C. R. & Menter, A. Cutaneous manifestations of gastrointestinal disease: Part II. J. Am. Acad. Dermatol. 68, 211.e1\u2013211.e33 (2013).","journal-title":"J. Am. Acad. Dermatol."},{"key":"BFnrgastro2013117_CR49","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/MD.0b013e318187cc9c","volume":"87","author":"D Farhi","year":"2008","unstructured":"Farhi, D.  et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore) 87, 281\u2013293 (2008).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2013117_CR50","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1155\/2005\/323914","volume":"19","author":"HJ Freeman","year":"2005","unstructured":"Freeman, H. J. Erythema nodosum and pyoderma gangrenosum in 50 patients with Crohn's disease. Can. J. Gastroenterol. 19, 603\u2013606 (2005).","journal-title":"Can. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR51","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1136\/pgmj.2004.031633","volume":"81","author":"LB Trost","year":"2005","unstructured":"Trost, L. B. & McDonnell, J. K. Important cutaneous manifestations of inflammatory bowel disease. Postgrad. Med. J. 81, 580\u2013585 (2005).","journal-title":"Postgrad. Med. J."},{"key":"BFnrgastro2013117_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.clindermatol.2007.10.018","volume":"26","author":"S Timani","year":"2008","unstructured":"Timani, S. & Mutasim, D. F. Skin manifestations of inflammatory bowel disease. Clin. Dermatol. 26, 265\u2013273 (2008).","journal-title":"Clin. Dermatol."},{"key":"BFnrgastro2013117_CR53","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000106584","volume":"215","author":"P Juillerat","year":"2007","unstructured":"Juillerat, P.  et al. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review. Dermatology 215, 245\u2013251 (2007).","journal-title":"Dermatology"},{"key":"BFnrgastro2013117_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/BOR.0b013e328341152f","volume":"23","author":"U Wollina","year":"2011","unstructured":"Wollina, U. & Haroske, G. Pyoderma gangraenosum. Curr. Opin. Rheumatol. 23, 50\u201356 (2011).","journal-title":"Curr. Opin. Rheumatol."},{"key":"BFnrgastro2013117_CR55","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1365-2133.1998.02087.x","volume":"138","author":"AM Farrell","year":"1998","unstructured":"Farrell, A. M., Black, M. M., Bracka, A. & Bunker, C. B. Pyoderma gangrenosum of the penis. Br. J. Dermatol. 138, 337\u2013340 (1998).","journal-title":"Br. J. Dermatol."},{"key":"BFnrgastro2013117_CR56","first-page":"420","volume":"96","author":"A Lopez San Roman","year":"2004","unstructured":"Lopez San Roman, A.  et al. Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab. Rev. Esp. Enferm. Dig. 96, 420\u2013422 (2004).","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"BFnrgastro2013117_CR57","first-page":"e8","volume":"5","author":"MA Fonder","year":"2006","unstructured":"Fonder, M. A., Cummins, D. L., Ehst, B. D., Anhalt, G. J. & Meyerle, J. H. Adalimumab therapy for recalcitrant pyoderma gangrenosum. J. Burns Wounds 5, e8 (2006).","journal-title":"J. Burns Wounds"},{"key":"BFnrgastro2013117_CR58","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/MPG.0b013e318093f4b0","volume":"46","author":"FA Jose","year":"2008","unstructured":"Jose, F. A. & Heyman, M. B. Extraintestinal manifestations of inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 46, 124\u2013133 (2008).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"BFnrgastro2013117_CR59","first-page":"55","volume":"9","author":"PE Evans","year":"2007","unstructured":"Evans, P. E. & Pardi, D. S. Extraintestinal manifestations of inflammatory bowel disease: focus on the musculoskeletal, dermatologic, and ocular manifestations. MedGenMed 9, 55 (2007).","journal-title":"MedGenMed"},{"key":"BFnrgastro2013117_CR60","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/00054725-200403000-00012","volume":"10","author":"R Mintz","year":"2004","unstructured":"Mintz, R., Feller, E. R., Bahr, R. L. & Shah, S. A. Ocular manifestations of inflammatory bowel disease. Inflamm. Bowel Dis. 10, 135\u2013139 (2004).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2013117_CR61","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0161-6420(03)00721-8","volume":"111","author":"CC Murphy","year":"2004","unstructured":"Murphy, C. C.  et al. Tumor necrosis factor \u03b1 blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 111, 352\u2013356 (2004).","journal-title":"Ophthalmology"},{"key":"BFnrgastro2013117_CR62","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1002\/ibd.21219","volume":"16","author":"U Navaneethan","year":"2010","unstructured":"Navaneethan, U. & Shen, B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease. Inflamm. Bowel Dis. 16, 1598\u20131619 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2013117_CR63","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/MCG.0b013e3181cadbe1","volume":"44","author":"CS Pitchumoni","year":"2010","unstructured":"Pitchumoni, C. S., Rubin, A. & Das, K. Pancreatitis in inflammatory bowel diseases. J. Clin. Gastroenterol. 44, 246\u2013253 (2010).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2013117_CR64","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1055\/s-2006-933561","volume":"26","author":"U Broome","year":"2006","unstructured":"Broome, U. & Bergquist, A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin. Liver Dis. 26, 31\u201341 (2006).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro2013117_CR65","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1751-2980.2011.00511.x","volume":"12","author":"PG Venkatesh","year":"2011","unstructured":"Venkatesh, P. G., Navaneethan, U. & Shen, B. Hepatobiliary disorders and complications of inflammatory bowel disease. J. Dig. Dis. 12, 245\u2013256 (2011).","journal-title":"J. Dig. Dis."},{"key":"BFnrgastro2013117_CR66","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/j.1572-0241.2000.01999.x","volume":"95","author":"WR Kim","year":"2000","unstructured":"Kim, W. R., Ludwig, J. & Lindor, K. D. Variant forms of cholestatic diseases involving small bile ducts in adults. Am. J. Gastroenterol. 95, 1130\u20131138 (2000).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR67","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1097\/PAS.0b013e318196d018","volume":"33","author":"M Joo","year":"2009","unstructured":"Joo, M.  et al. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case\u2013control study. Am. J. Surg. Pathol. 33, 854\u2013862 (2009).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrgastro2013117_CR68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1067\/mge.2002.125367","volume":"56","author":"RM Soetikno","year":"2002","unstructured":"Soetikno, R. M., Lin, O. S., Heidenreich, P. A., Young, H. S. & Blackstone, M. O. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest. Endosc. 56, 48\u201354 (2002).","journal-title":"Gastrointest. Endosc."},{"key":"BFnrgastro2013117_CR69","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"EV Loftus Jr","year":"2005","unstructured":"Loftus, E. V. Jr  et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54, 91\u201396 (2005).","journal-title":"Gut"},{"key":"BFnrgastro2013117_CR70","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/00054725-200501000-00009","volume":"11","author":"JA Talwalkar","year":"2005","unstructured":"Talwalkar, J. A. & Lindor, K. D. Primary sclerosing cholangitis. Inflamm. Bowel Dis. 11, 62\u201372 (2005).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2013117_CR71","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1056\/NEJM199703063361003","volume":"336","author":"KD Lindor","year":"1997","unstructured":"Lindor, K. D. Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. N. Engl. J. Med. 336, 691\u2013695 (1997).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2013117_CR72","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1038\/ajg.2011.156","volume":"106","author":"JE Eaton","year":"2011","unstructured":"Eaton, J. E.  et al. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am. J. Gastroenterol. 106, 1638\u20131645 (2011).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR73","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/S0016-5085(99)70507-X","volume":"116","author":"MA Brink","year":"1999","unstructured":"Brink, M. A.  et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn's disease. Gastroenterology 116, 1420\u20131427 (1999).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013117_CR74","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000201483","volume":"58","author":"A Damiao","year":"1997","unstructured":"Damiao, A.  et al. Gallbladder hypokinesia in Crohn's disease. Digestion 58, 458\u2013463 (1997).","journal-title":"Digestion"},{"key":"BFnrgastro2013117_CR75","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0002-9610(83)90175-7","volume":"145","author":"HA Pitt","year":"1983","unstructured":"Pitt, H. A.  et al. Increased risk of cholelithiasis with prolonged total parenteral nutrition. Am. J. Surg. 145, 106\u2013112 (1983).","journal-title":"Am. J. Surg."},{"key":"BFnrgastro2013117_CR76","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1111\/j.1440-1746.2006.04559.x","volume":"21","author":"DM Nathan","year":"2006","unstructured":"Nathan, D. M., Angus, P. W. & Gibson, P. R. Hepatitis B and C virus infections and anti-tumor necrosis factor-alpha therapy: guidelines for clinical approach. J. Gastroenterol. Hepatol. 21, 1366\u20131371 (2006).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013117_CR77","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.cgh.2009.01.004","volume":"7","author":"CA Siegel","year":"2009","unstructured":"Siegel, C. A., Marden, S. M., Persing, S. M., Larson, R. J. & Sands, B. E. Risk of lymphoma associated with combination anti-tumor necrosis factor and immunomodulator therapy for the treatment of Crohn's disease: a meta-analysis. Clin. Gastroenterol. Hepatol. 7, 874\u2013881 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013117_CR78","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1136\/gut.2008.163279","volume":"57","author":"M Shale","year":"2008","unstructured":"Shale, M., Kanfer, E., Panaccione, R. & Ghosh, S. Hepatosplenic T cell lymphoma in inflammatory bowel disease. Gut 57, 1639\u20131641 (2008).","journal-title":"Gut"},{"key":"BFnrgastro2013117_CR79","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1160\/TH11-09-0611","volume":"107","author":"YI Tichelaar","year":"2012","unstructured":"Tichelaar, Y. I., Kluin-Nelemans, H. J. & Meijer, K. Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review. Thromb. Haemost. 107, 827\u2013837 (2012).","journal-title":"Thromb. Haemost."},{"key":"BFnrgastro2013117_CR80","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1055\/s-0031-1273086","volume":"37","author":"F Di Fabio","year":"2011","unstructured":"Di Fabio, F., Lykoudis, P. & Gordon, P. H. Thromboembolism in inflammatory bowel disease: an insidious association requiring a high degree of vigilance. Semin. Thromb. Hemost. 37, 220\u2013225 (2011).","journal-title":"Semin. Thromb. Hemost."},{"key":"BFnrgastro2013117_CR81","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ncpgasthep0190","volume":"2","author":"IE Koutroubakis","year":"2005","unstructured":"Koutroubakis, I. E. Therapy insight: Vascular complications in patients with inflammatory bowel disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 266\u2013272 (2005).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"BFnrgastro2013117_CR82","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.3748\/wjg.14.4440","volume":"14","author":"G Tsiolakidou","year":"2008","unstructured":"Tsiolakidou, G. & Koutroubakis, I. E. Thrombosis and inflammatory bowel disease\u2014the role of genetic risk factors. World J. Gastroenterol. 14, 4440\u20134444 (2008).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2013117_CR83","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s00535-011-0441-7","volume":"46","author":"J Liang","year":"2011","unstructured":"Liang, J.  et al. Factor V Leiden and inflammatory bowel disease: a systematic review and meta-analysis. J. Gastroenterol. 46, 1158\u20131166 (2011).","journal-title":"J. Gastroenterol."},{"key":"BFnrgastro2013117_CR84","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/j.1365-2036.2011.04864.x","volume":"34","author":"A Oussalah","year":"2011","unstructured":"Oussalah, A., Gueant, J. L. & Peyrin-Biroulet, L. Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment. Pharmacol. Ther. 34, 1173\u20131184 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2013117_CR85","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.3748\/wjg.v16.i39.4952","volume":"16","author":"A Yilmaz","year":"2010","unstructured":"Yilmaz, A.  et al. Pulmonary involvement in inflammatory bowel disease. World J. Gastroenterol. 16, 4952\u20134957 (2010).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2013117_CR86","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.2214\/AJR.10.5353","volume":"197","author":"SL Betancourt","year":"2011","unstructured":"Betancourt, S. L., Palacio, D., Jimenez, C. A., Martinez, S. & Marom, E. M. Thoracic manifestations of inflammatory bowel disease. AJR Am. J. Roentgenol. 197, W452\u2013W456 (2011).","journal-title":"AJR Am. J. Roentgenol."},{"key":"BFnrgastro2013117_CR87","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.crohns.2010.03.008","volume":"4","author":"B Basseri","year":"2010","unstructured":"Basseri, B., Enayati, P., Marchevsky, A. & Papadakis, K. A. Pulmonary manifestations of inflammatory bowel disease: case presentations and review. J. Crohns Colitis 4, 390\u2013397 (2010).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2013117_CR88","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00408-010-9259-y","volume":"188","author":"M Abu-Hijleh","year":"2010","unstructured":"Abu-Hijleh, M., Evans, S. & Aswad, B. Pleuropericarditis in a patient with inflammatory bowel disease: a case presentation and review of the literature. Lung 188, 505\u2013510 (2010).","journal-title":"Lung"},{"key":"BFnrgastro2013117_CR89","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1111\/j.1572-0241.1998.156_b.x","volume":"93","author":"DS Pardi","year":"1998","unstructured":"Pardi, D. S., Tremaine, W. J., Sandborn, W. J. & McCarthy, J. T. Renal and urologic complications of inflammatory bowel disease. Am. J. Gastroenterol. 93, 504\u2013514 (1998).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR90","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/ibd.21468","volume":"17","author":"K Oikonomou","year":"2011","unstructured":"Oikonomou, K., Kapsoritakis, A., Eleftheriadis, T., Stefanidis, I. & Potamianos, S. Renal manifestations and complications of inflammatory bowel disease. Inflamm. Bowel Dis. 17, 1034\u20131045 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2013117_CR91","doi-asserted-by":"publisher","first-page":"c89","DOI":"10.1159\/000326682","volume":"119","author":"KA Oikonomou","year":"2011","unstructured":"Oikonomou, K. A., Kapsoritakis, A. N., Stefanidis, I. & Potamianos, S. P. Drug-induced nephrotoxicity in inflammatory bowel disease. Nephron. Clin. Pract. 119, c89\u2013c94 (2011).","journal-title":"Nephron. Clin. Pract."},{"key":"BFnrgastro2013117_CR92","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1046\/j.1365-2036.2001.01041.x","volume":"15","author":"JS Fraser","year":"2001","unstructured":"Fraser, J. S., Muller, A. F., Smith, D. J., Newman, D. J. & Lamb, E. J. Renal tubular injury is present in acute inflammatory bowel disease prior to the introduction of drug therapy. Aliment. Pharmacol. Ther. 15, 1131\u20131137 (2001).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2013117_CR93","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3748\/wjg.v12.i5.739","volume":"12","author":"AC Poulou","year":"2006","unstructured":"Poulou, A. C.  et al. Microproteinuria in patients with inflammatory bowel disease: is it associated with the disease activity or the treatment with 5-aminosalicylic acid? World J. Gastroenterol. 12, 739\u2013746 (2006).","journal-title":"World J. Gastroenterol."},{"key":"BFnrgastro2013117_CR94","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1053\/gast.2002.36613","volume":"123","author":"H Izzedine","year":"2002","unstructured":"Izzedine, H.  et al. Primary chronic interstitial nephritis in Crohn's disease. Gastroenterology 123, 1436\u20131440 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013117_CR95","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1046\/j.1365-2036.2001.00940.x","volume":"15","author":"KR Herrlinger","year":"2001","unstructured":"Herrlinger, K. R.  et al. Minimal renal dysfunction in inflammatory bowel disease is related to disease activity but not to 5-ASA use. Aliment. Pharmacol. Ther. 15, 363\u2013369 (2001).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2013117_CR96","first-page":"w13580","volume":"142","author":"L Obici","year":"2012","unstructured":"Obici, L. & Merlini, G. AA amyloidosis: basic knowledge, unmet needs and future treatments. Swiss Med. Wkly 142, w13580 (2012).","journal-title":"Swiss Med. Wkly"},{"key":"BFnrgastro2013117_CR97","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1155\/2002\/204614","volume":"16","author":"H Ben-Ami","year":"2002","unstructured":"Ben-Ami, H.  et al. Diagnosis and treatment of urinary tract complications in Crohn's disease: an experience over 15 years. Can. J. Gastroenterol. 16, 225\u2013229 (2002).","journal-title":"Can. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR98","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1046\/j.1464-410X.2002.02739.x","volume":"89","author":"N McConnell","year":"2002","unstructured":"McConnell, N., Campbell, S., Gillanders, I., Rolton, H. & Danesh, B. Risk factors for developing renal stones in inflammatory bowel disease. BJU Int. 89, 835\u2013841 (2002).","journal-title":"BJU Int."},{"issue":"12 Suppl.","key":"BFnrgastro2013117_CR99","doi-asserted-by":"publisher","first-page":"S640","DOI":"10.1111\/j.1572-0241.2006.00976.x","volume":"101","author":"S Kane","year":"2006","unstructured":"Kane, S. Urogenital complications of Crohn's disease. Am. J. Gastroenterol. 101 (12 Suppl.), S640\u2013S643 (2006).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR100","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1136\/bmj.328.7453.1420","volume":"328","author":"MS Parmar","year":"2004","unstructured":"Parmar, M. S. Kidney stones. BMJ 328, 1420\u20131424 (2004).","journal-title":"BMJ"},{"key":"BFnrgastro2013117_CR101","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","volume":"86","author":"M Ramos-Casals","year":"2007","unstructured":"Ramos-Casals, M.  et al. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86, 242\u2013251 (2007).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrgastro2013117_CR102","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0140-6736(95)90013-6","volume":"345","author":"A Geissler","year":"1995","unstructured":"Geissler, A.  et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet 345, 897\u2013898 (1995).","journal-title":"Lancet"},{"key":"BFnrgastro2013117_CR103","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1002\/ibd.23011","volume":"19","author":"S Singh","year":"2012","unstructured":"Singh, S., Kumar, N., Loftus, E. V. Jr & Kane, S. V. Neurologic complications in patients with inflammatory bowel disease: Increasing relevance in the era of biologics. Inflamm. Bowel Dis. 19, 864\u2013872 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2013117_CR104","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.crohns.2009.10.005","volume":"4","author":"CD Zois","year":"2010","unstructured":"Zois, C. D., Katsanos, K. H., Kosmidou, M. & Tsianos, E. V. Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights. J. Crohns Colitis 4, 115\u2013124 (2010).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2013117_CR105","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1159\/000068900","volume":"206","author":"T Bogenrieder","year":"2003","unstructured":"Bogenrieder, T., Rogler, G., Vogt, T., Landthaler, M. & Stolz, W. Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent. Dermatology 206, 273\u2013278 (2003).","journal-title":"Dermatology"},{"key":"BFnrgastro2013117_CR106","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/mus.20924","volume":"37","author":"JP Stubgen","year":"2008","unstructured":"Stubgen, J. P. Tumor necrosis factor-alpha antagonists and neuropathy. Muscle Nerve 37, 281\u2013292 (2008).","journal-title":"Muscle Nerve"},{"key":"BFnrgastro2013117_CR107","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/01.meg.0000250589.45984.b4","volume":"19","author":"K Vadikolias","year":"2007","unstructured":"Vadikolias, K.  et al. Acute paraplegia after the initiation of anti-tumour necrosis factor-alpha therapy for Crohn's disease. Eur. J. Gastroenterol. Hepatol 19, 159\u2013162 (2007).","journal-title":"Eur. J. Gastroenterol. Hepatol"},{"key":"BFnrgastro2013117_CR108","doi-asserted-by":"publisher","first-page":"595970","DOI":"10.1155\/2012\/595970","volume":"2012","author":"C Ott","year":"2012","unstructured":"Ott, C., Liebold, A., Takses, A., Strauch, U. G. & Obermeier, F. High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort. Gastroenterol. Res. Pract. 2012, 595970 (2012).","journal-title":"Gastroenterol. Res. Pract."},{"key":"BFnrgastro2013117_CR109","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.crohns.2010.07.008","volume":"4","author":"M Voegtlin","year":"2010","unstructured":"Voegtlin, M.  et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals. J. Crohns Colitis 4, 642\u2013648 (2010).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2013117_CR110","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3109\/00365521.2010.533382","volume":"46","author":"P Bager","year":"2011","unstructured":"Bager, P.  et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand. J. Gastroenterol. 46, 304\u2013309 (2011).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2013117_CR111","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1002\/ibd.22906","volume":"18","author":"C Hwang","year":"2012","unstructured":"Hwang, C., Ross, V. & Mahadevan, U. Micronutrient deficiencies in inflammatory bowel disease: from A to zinc. Inflamm. Bowel Dis. 18, 1961\u20131981 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2013117_CR112","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1002\/1097-0142(19940515)73:10<2535::AID-CNCR2820731014>3.0.CO;2-5","volume":"73","author":"C Leitgeb","year":"1994","unstructured":"Leitgeb, C., Pecherstorfer, M., Fritz, E. & Ludwig, H. Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer 73, 2535\u20132542 (1994).","journal-title":"Cancer"},{"key":"BFnrgastro2013117_CR113","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/ibd.20285","volume":"13","author":"C Gasche","year":"2007","unstructured":"Gasche, C.  et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm. Bowel Dis. 13, 1545\u20131553 (2007).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2013117_CR114","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2174\/156720112801323026","volume":"9","author":"AJ Kent","year":"2012","unstructured":"Kent, A. J., Blackwell, V. J. & Travis, S. P. What is the optimal treatment for anemia in inflammatory bowel disease? Curr. Drug Deliv. 9, 356\u2013366 (2012).","journal-title":"Curr. Drug Deliv."},{"key":"BFnrgastro2013117_CR115","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/ajcn\/8.3.285","volume":"8","author":"GB Glass","year":"1960","unstructured":"Glass, G. B. & Mersheimer, W. L. Metabolic turnover of vitamin B12 in the normal and diseased liver. Am. J. Clin. Nutr. 8, 285\u2013292 (1960).","journal-title":"Am. J. Clin. Nutr."},{"key":"BFnrgastro2013117_CR116","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1136\/gut.40.2.228","volume":"40","author":"I Bjarnason","year":"1997","unstructured":"Bjarnason, I.  et al. Reduced bone density in patients with inflammatory bowel disease. Gut 40, 228\u2013233 (1997).","journal-title":"Gut"},{"key":"BFnrgastro2013117_CR117","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1007\/BF01296010","volume":"37","author":"F Pigot","year":"1992","unstructured":"Pigot, F.  et al. Low bone mineral density in patients with inflammatory bowel disease. Dig. Dis. Sci. 37, 1396\u20131403 (1992).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2013117_CR118","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1136\/gut.28.4.410","volume":"28","author":"JE Compston","year":"1987","unstructured":"Compston, J. E.  et al. Osteoporosis in patients with inflammatory bowel disease. Gut 28, 410\u2013415 (1987).","journal-title":"Gut"},{"key":"BFnrgastro2013117_CR119","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1053\/gast.2003.50106","volume":"124","author":"CN Bernstein","year":"2003","unstructured":"Bernstein, C. N., Leslie, W. D. & Leboff, M. S. AGA technical review on osteoporosis in gastrointestinal diseases. Gastroenterology 124, 795\u2013841 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2013117_CR120","doi-asserted-by":"publisher","first-page":"795","DOI":"10.7326\/0003-4819-133-10-200011210-00012","volume":"133","author":"CN Bernstein","year":"2000","unstructured":"Bernstein, C. N., Blanchard, J. F., Leslie, W., Wajda, A. & Yu, B. N. The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study. Ann. Intern. Med. 133, 795\u2013799 (2000).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro2013117_CR121","first-page":"469","volume":"95","author":"P Vestergaard","year":"2004","unstructured":"Vestergaard, P. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med. 95, 469\u2013480 (2004).","journal-title":"Minerva Med."},{"key":"BFnrgastro2013117_CR122","doi-asserted-by":"crossref","unstructured":"[No authors listed] American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. Gastroenterology 124, 791\u2013794 (2003).","DOI":"10.1053\/gast.2003.50107"},{"key":"BFnrgastro2013117_CR123","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","volume":"15","author":"DM Reid","year":"2000","unstructured":"Reid, D. M.  et al. Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study. J. Bone Miner. Res. 15, 1006\u20131013 (2000).","journal-title":"J. Bone Miner. Res."},{"key":"BFnrgastro2013117_CR124","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJM199807303390502","volume":"339","author":"KG Saag","year":"1998","unstructured":"Saag, K. G.  et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N. Engl. J. Med. 339, 292\u2013299 (1998).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Gastroenterology &amp; Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.117","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2013.117.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:47:42Z","timestamp":1684453662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2013.117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,9]]},"references-count":124,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["BFnrgastro2013117"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2013.117","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,9]]}}}